BLFS logo

BLFS
Biolife Solutions Inc

2,929
Mkt Cap
$1.17B
Volume
855,114.00
52W High
$29.62
52W Low
$17.86
PE Ratio
-85.93
BLFS Fundamentals
Price
$24.75
Prev Close
$24.00
Open
$23.80
50D MA
$20.55
Beta
1.54
Avg. Volume
362,883.60
EPS (Annual)
-$0.3124
P/B
3.15
Rev/Employee
$620,735.48
$1,083.66
Loading...
Loading...
News
all
press releases
BioLife Solutions, Inc. (BLFS) Tops Q1 Earnings and Revenue Estimates
BioLife Solutions (BLFS) delivered earnings and revenue surprises of +700.00% and +7.78%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago
News Placeholder
More News
News Placeholder
BioLife Solutions Reports First Quarter 2026 Financial Results
BioLife Solutions Reports First Quarter 2026 Financial Results BioLife Solutions Reports First Quarter 2026 Financial Results PR Newswire BOTHELL, Wash., May 7, 2026 Total revenue of $27.5 million...
PR Newswire·14d ago
News Placeholder
Quanterix Corporation (QTRX) Reports Q1 Loss, Lags Revenue Estimates
Quanterix (QTRX) delivered earnings and revenue surprises of -25.81% and -0.67%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·15d ago
News Placeholder
ResMed (RMD) Surpasses Q3 Earnings and Revenue Estimates
ResMed (RMD) delivered earnings and revenue surprises of +2.58% and +0.79%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·21d ago
News Placeholder
BioLife Solutions (BLFS) Expected to Announce Quarterly Earnings on Thursday
BioLife Solutions (NASDAQ:BLFS) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...
MarketBeat·21d ago
News Placeholder
Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway
Medical Products stocks face tariff and cost pressures, but Phibro Animal Health and peers leverage innovation, AI and demand trends to drive growth.
Zacks·23d ago
News Placeholder
4 Medical Product Stocks to Buy From a Challenging Industry
The Zacks Medical - Products industry faces macro headwinds, keeping growth under pressure in 2026, but steady demand may continue. PAHC, BLFS, OMER and BWAY reflect the favorable fundamentals.
Zacks·24d ago
News Placeholder
BioLife Solutions (NASDAQ:BLFS) Stock Crosses Below 200 Day Moving Average - Time to Sell?
BioLife Solutions (NASDAQ:BLFS) Share Price Passes Below Two Hundred Day Moving Average - Should You Sell...
MarketBeat·27d ago
News Placeholder
BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026 BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026...
PR Newswire·28d ago
News Placeholder
BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal CryoCase
BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal CryoCase BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal CryoCase PR Newswire BOTHELL, Wash...
PR Newswire·30d ago
<
1
2
...
>

Latest BLFS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.